Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EUROLyser Diagnostica is an Austrian in vitro diagnostics company focused on point-of-care testing systems and assay kits for human and veterinary use. The company develops and commercializes compact analyzers, including the CUBE-S and earlier solo/smart systems, together with reagent cartridges and connected software intended for physician offices and near-patient testing. Its menu spans clinical chemistry, inflammation, cardiometabolic, coagulation, renal, diabetes, and selected screening parameters, with products marketed through distributor networks in Europe, the United States, Japan, and other regions. EUROLyser emphasizes maintenance-light instruments, rapid turnaround, and laboratory-style reagent chemistry adapted for decentralized settings. The company is active commercially and operates as an affiliate of Mars, Incorporated.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EUROLyser Diagnostica.